is the fda banning bpc 157 may take an important step toward opening peptide floodgates this week This Isn't Really About BPC-157:

This Isn't Really About BPC 157: The Bigger Picture of the FDA's Meeting on Peptides A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA to discuss easing restrictions on peptides despite safety concerns US healthcare The Guardian

SKU: 83117570169 · From clintoncounty708.com